Cu-64-RYM2

N/A

Report date: 2026/04/07 20:00:20

NME

Base Information

Drug NameCu-64-RYM2

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agent

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsAortic Aneurysm, Abdominal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesWashington University School Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesWashington University School Of Medicine

Inactive CompaniesN/A

Active IndicationsAortic Aneurysm, Abdominal

Inactive IndicationsN/A

Other Information

ATC CodeN/A